Insider Trading Arrangements	3 Months Ended
Jul. 04, 2026 shares
Trading Arrangements, by Individual [Table]
Material Terms of Trading Arrangement	During the fiscal quarter ended July 4, 2026, the individuals listed below serving as directors (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted trading arrangements for the sale of the Company's securities as described in Item 408 of Regulation S-K of the Securities Act. The material terms of the plans which are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act ("Rule 10b5-1 Plan"), are as follows: Raanan Zilberman, Director, adopted a Rule 10b5-1 Plan on June 8, 2026. Under this plan, an aggregate of 24,084 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on September 30, 2027. Ruta Zandman, Director, adopted a Rule 10b5-1 Plan on June 11, 2026. Under this plan, an aggregate of 78,507 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on January 30, 2027. Dr. Renee B. Booth, Director, adopted a Rule 10b5-1 Plan on June 12, 2026. Under this plan, an aggregate of 8,255 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on September 13, 2027. Dr. Abraham Ludomirski, Director, adopted a Rule 10b5-1 Plan on June 12, 2026. Under this plan, an aggregate of 10,000 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on June 1, 2027. Dr. Michiko Kurahashi, Director, adopted a Rule 10b5-1 Plan on June 16, 2026. Under this plan, an aggregate of 4,000 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on June 19, 2027.
Raanan Zilberman [Member]
Trading Arrangements, by Individual [Table]
Name	Raanan Zilberman
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	June 8, 2026
Aggregate Available	24,084
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Terminated	false
Expiration Date	September 30, 2027
Ruta Zandman [Member]
Trading Arrangements, by Individual [Table]
Name	Ruta Zandman
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	June 11, 2026
Aggregate Available	78,507
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Terminated	false
Expiration Date	January 30, 2027
Dr. Renee B. Booth [Member]
Trading Arrangements, by Individual [Table]
Name	Dr. Renee B. Booth
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	June 12, 2026
Aggregate Available	8,255
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Terminated	false
Expiration Date	September 13, 2027
Dr. Abraham Ludomirski [Member]
Trading Arrangements, by Individual [Table]
Name	Dr. Abraham Ludomirski
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	June 12, 2026
Aggregate Available	10,000
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Terminated	false
Expiration Date	June 1, 2027
Dr. Michiko Kurahashi [Member]
Trading Arrangements, by Individual [Table]
Name	Dr. Michiko Kurahashi
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	June 16, 2026
Aggregate Available	4,000
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Terminated	false
Expiration Date	June 19, 2027

Insider Trading Arrangements

3 Months Ended

Jul. 04, 2026

Trading Arrangements, by Individual [Table]

During the fiscal quarter ended July 4, 2026, the individuals listed below serving as directors (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted trading arrangements for the sale of the Company's securities as described in Item 408 of Regulation S-K of the Securities Act. The material terms of the plans which are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act ("Rule 10b5-1 Plan"), are as follows:

Raanan Zilberman, Director, adopted a Rule 10b5-1 Plan on June 8, 2026. Under this plan, an aggregate of 24,084 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on September 30, 2027.

Ruta Zandman, Director, adopted a Rule 10b5-1 Plan on June 11, 2026. Under this plan, an aggregate of 78,507 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on January 30, 2027.

Dr. Renee B. Booth, Director, adopted a Rule 10b5-1 Plan on June 12, 2026. Under this plan, an aggregate of 8,255 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on September 13, 2027.

Dr. Abraham Ludomirski, Director, adopted a Rule 10b5-1 Plan on June 12, 2026. Under this plan, an aggregate of 10,000 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on June 1, 2027.

Dr. Michiko Kurahashi, Director, adopted a Rule 10b5-1 Plan on June 16, 2026. Under this plan, an aggregate of 4,000 shares of common stock, net of any portion of such shares which are surrendered to the Company or sold to cover withholding taxes, may be sold before the plan expires on June 19, 2027.